ScreenerHero

USPHU.S. Physical Therapy, Inc.

NYSE · US · Healthcare · Medical Care Facilities · usph.com
78.21USD-1.26%Mkt Cap: 1.17B $P/E: 460.06

U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Servic…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$95.21BUSDP/E 14.4
FRE
Fresenius SE & Co. KGaA
$28.53BUSDP/E 16.8
THC
Tenet Healthcare Corporation
$22.61BUSDP/E 10.9
FME
Fresenius Medical Care AG & Co. KGaA
$11.72BUSDP/E 12.1
FMS
Fresenius Medical Care AG & Co. KGaA
$12.47BUSDP/E 12.2
EHC
Encompass Health Corporation
$11.87BUSDP/E 20.1
DVA
DaVita Inc.
$11.16BUSDP/E 14.7
ENSG
The Ensign Group, Inc.
$10.46BUSDP/E 28.1
UHS
Universal Health Services, Inc. Class B
$10.45BUSDP/E 7.2
CHE
Chemed Corporation
$7.07BUSDP/E 27.2
PACS
PACS Group Inc.
$7.00BUSDP/E 25.9
LFST
LifeStance Health Group Inc. Common Stock
$4.76BUSDP/E 95.9
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.46BUSDP/E 22.6
MCOV-B
Medicover AB (publ)
$3.50BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.66BUSDP/E 26.2
OPCH
Option Care Health, Inc.
$3.55BUSDP/E 18.0
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.3
BKD
Brookdale Senior Living Inc.
$2.82BUSD
EMEIS
Emeis SA
$2.45BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.59BUSD

Key Statistics

Company
Market Cap1.17B $
Enterprise Value1.84B $
Revenue (TTM)804.27M $
Gross Profit149.69M $
Net Income (TTM)15.06M $
Revenue/Share53.08 USD
Last Price78.21 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4.7K
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)460.06
P/E (Forward)23.06
PEG2.88
EV/EBITDA18.05
EV/Revenue2.29
P/S1.45
P/B2.53
EPS (TTM)0.16
EPS (Forward)3.38
52W Range
58.1957% of range93.50
52W High93.50 USD
52W Low58.19 USD
Profitability
Gross Margin19.17%
Oper. Margin11.13%
EBITDA Margin12.68%
Profit Margin1.93%
ROE3.16%
ROA1.25%
Growth
Revenue Growth8.50%
Earnings Growth-56.50%
Cash Flow & Leverage
Operating CF75.06M $
CapEx (TTM)14.07M $
FCF Margin5.13%
FCF Yield3.54%
Net Debt359.53M $
Net Debt/EBITDA3.52
Balance Sheet
Debt/Equity0.66
Current Ratio1.27
Quick Ratio1.13
Book Value/Sh30.79 USD
Cash/Share1.760 USD
Dividends
Fwd Div Rate1.840 USD
Trail. Div Rate1.820 USD
Div. Yield2.36%
5Y Avg Yield1.82%
Payout Ratio1070.59%
Ex-Div DateAug 21, 2026
Pay DateSep 11, 2026
Splits
Last Split3:2
Split DateJun 29, 2001
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)95.00 USD
Upside (mean)+21.5%
Target Range88.00 USD – 100.00 USD
$88.00+21.5% to mean$100.00
# Analysts6
Ownership
Shares Out.14.92M
Float14.54M
Insiders2.51%
Institutions110.94%
Short Interest
Short Ratio4.5d
Short % Float8.87%
Short % Out.7.41%
Shares Short1.11M
Short (prev mo.)1.06M
Technical
SMA 5073.20 (+6.8%)
SMA 20075.47 (+3.6%)
Beta1.13
S&P 52W Chg18.16%
Avg Vol (30d)201.86K
Avg Vol (10d)193.75K
Technical Indicators
RSI (14)52.7
MACD1.9354
MACD Signal2.3863
MACD Hist.-0.4510
BB Upper83.93 USD
BB Middle78.77 USD
BB Lower73.61 USD
BB Width13.09%
ATR (14)3.111 USD
Vol Ratio (20d)0.57x